83 related articles for article (PubMed ID: 3499860)
1. Phorbol ester and epidermal growth factor receptors in human breast cancer.
Wyss R; Fabbro D; Regazzi R; Borner C; Takahashi A; Eppenberger U
Anticancer Res; 1987; 7(4B):721-7. PubMed ID: 3499860
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer.
Kim HJ; Cui X; Hilsenbeck SG; Lee AV
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1013s-1018s. PubMed ID: 16467118
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship.
Fabbro D; Küng W; Roos W; Regazzi R; Eppenberger U
Cancer Res; 1986 Jun; 46(6):2720-5. PubMed ID: 3008998
[TBL] [Abstract][Full Text] [Related]
6. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L
Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
[TBL] [Abstract][Full Text] [Related]
7. Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer.
Pekonen F; Partanen S; Mäkinen T; Rutanen EM
Cancer Res; 1988 Mar; 48(5):1343-7. PubMed ID: 2963690
[TBL] [Abstract][Full Text] [Related]
8. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
[TBL] [Abstract][Full Text] [Related]
9. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
Colburn NH; Gindhart TD; Hegamyer GA; Blumberg PM; Delclos KB; Magun BE; Lockyer J
Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
[TBL] [Abstract][Full Text] [Related]
10. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.
Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP
J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969
[TBL] [Abstract][Full Text] [Related]
11. Relationship between biological responsiveness to phorbol esters and receptor levels in GH4C1 rat pituitary cells.
Jaken S; Tashjian AH; Blumberg PM
Cancer Res; 1981 Dec; 41(12 Pt 1):4956-60. PubMed ID: 6272986
[TBL] [Abstract][Full Text] [Related]
12. Binding of phorbol dibutyrate and epidermal growth factor to cultured human epidermal cells.
Greenebaum E; Nicolaides M; Eisinger M; Vogel RH; Weinstein IB
J Natl Cancer Inst; 1983 Mar; 70(3):435-41. PubMed ID: 6300498
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.
Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Branković-Magić M; Kanjer K; Gavrilović D; Mitrović L; Borojević N; Vukotić D; Spuzić I
J Exp Clin Cancer Res; 1999 Sep; 18(3):347-55. PubMed ID: 10606181
[TBL] [Abstract][Full Text] [Related]
14. Association among an autocrine parameter (EGF-R) and endocrine parameters (ER and PR) in locoregional breast cancer.
Nikolić-Vukosavljević D; Kanjer K; Branković-Magić M; Spuzić I
Neoplasma; 1994; 41(3):137-40. PubMed ID: 7935980
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA
J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137
[TBL] [Abstract][Full Text] [Related]
16. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.
Cui X; Schiff R; Arpino G; Osborne CK; Lee AV
J Clin Oncol; 2005 Oct; 23(30):7721-35. PubMed ID: 16234531
[TBL] [Abstract][Full Text] [Related]
17. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
[TBL] [Abstract][Full Text] [Related]
18. HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer.
Zeillinger R; Kury F; Czerwenka K; Kubista E; Sliutz G; Knogler W; Huber J; Zielinski C; Reiner G; Jakesz R
Oncogene; 1989 Jan; 4(1):109-14. PubMed ID: 2915900
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
[TBL] [Abstract][Full Text] [Related]
20. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.
Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA
J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]